Side-by-side comparison of AI visibility scores, market position, and capabilities
Commercial/defense aircraft maker in deep crisis; $66.5B FY2024 revenue; 2024 Alaska Airlines door blowout + IAM strike + $14B equity raise; new CEO Kelly Ortberg Aug 2024; Airbus gaining market share.
Boeing is one of the world's two dominant commercial aircraft manufacturers and a major defense and space contractor, founded in 1916 by William Boeing in Seattle, Washington and now headquartered in Arlington, Virginia—relocated from Chicago in 2022. The company trades on NYSE (BA) and reported approximately $66.5 billion in revenues for FY2024 under CEO Kelly Ortberg, who replaced Dave Calhoun in August 2024 amid a deepening quality and manufacturing crisis. Boeing's commercial aircraft division—the 737 MAX, 787 Dreamliner, and 777X—has been plagued by a series of safety, quality, and production crises beginning with the two fatal 737 MAX crashes in 2018 and 2019 (Lion Air and Ethiopian Airlines, killing 346 people), followed by a door plug blowout on an Alaska Airlines 737-9 MAX in January 2024 that triggered renewed FAA production rate restrictions and public confidence damage.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.